tiprankstipranks
CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A (BR:CHME34)
:CHME34
Brazil Market
CHME34
CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A
RESEARCH TOOLSreports

CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A (CHME34) Price & Analysis

― Followers

CHME34 Stock Chart & Stats

$67.69
$4.22(6.65%)
―
--
Day’s Range― - ―
52-Week Range<$0.01 - $86.02
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
R$488.77B
Enterprise Value$426.46K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)21835.5
Beta-0.17
Next Earnings
Oct 28, 2026
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding7,191,522,500
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A

CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A News

CME Group to launch E-nano equity index futures on August 24, pending review
CME Group to launch E-nano equity index futures on August 24, pending review
CME Group (CME) announced plans to expand its smaller-sized contract suite with the launch of E-nano equity index...
11h ago
CME
CME Group price target raised to $250 from $249 at JPMorgan
CME Group price target raised to $250 from $249 at JPMorgan
JPMorgan raised the firm’s price target on CME Group (CME) to $250 from $249 and keeps an Underweight...
11d ago
CME
CME Group price target raised to $330 from $324 at Morgan Stanley
CME Group price target raised to $330 from $324 at Morgan Stanley
Morgan Stanley analyst Michael Cyprys raised the firm’s price target on CME Group (CME) to $330 from $324...
11d ago
CME
CME Group price target raised to $230 from $226 at BofA
CME Group price target raised to $230 from $226 at BofA
BofA analyst Craig Siegenthaler raised the firm’s price target on CME Group (CME) to $230 from $226 and...
12d ago
BGC
CME
Early notable gainers among liquid option names on July 22nd
Early notable gainers among liquid option names on July 22nd
Notable gainers among liquid option names this morning include Super Micro (SMCI) $31.08 +5.58, Wabtec (WAB) $291.20 +27.67,...
12d ago
CME
EQT
Morning Movers: AT&T jumps, GE Vernova slips following reports
Morning Movers: AT&T jumps, GE Vernova slips following reports
Stock futures are lower as investors adopt a cautious stance ahead of a round of Big Tech earnings,...
12d ago
T
PM
CME Group reports Q2 adjusted EPS $2.99, consensus $2.91
CME Group reports Q2 adjusted EPS $2.99, consensus $2.91
Reports Q2 revenue $1.71B, consensus $1.68B. “The first half of 2026 was the strongest in CME Group’s (CME)...
13d ago
CME
CME Group reports Q2 ADV 29.8M contracts
CME Group reports Q2 ADV 29.8M contracts
Second-quarter 2026 average daily volume was the third highest quarterly ADV reaching 29.8M contracts, which included non-U.S. ADV...
13d ago
CME
Neutral Stance Reiterated on CME as Solid Fundamentals Meet Valuation Limits; $260 Price Target Maintained
Neutral Stance Reiterated on CME as Solid Fundamentals Meet Valuation Limits; $260 Price Target Maintained
UBS analyst Alex Kramm maintained a Hold rating on CME Group today and set a price target of...
11d ago
CME
Morgan Stanley’s Cyprys Maintains Overweight on CME, Lifts Price Target to $330 on New Products and Structural Growth Runway
Morgan Stanley’s Cyprys Maintains Overweight on CME, Lifts Price Target to $330 on New Products and Structural Growth Runway
Analyst Michael Cyprys from Morgan Stanley reiterated a Buy rating on CME Group and increased the price target...
12d ago
CME

CHME34 FAQ

What was CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A’s price range in the past 12 months?
CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A lowest stock price was <$0.01 and its highest was $86.02 in the past 12 months.
    What is CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A’s market cap?
    CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A’s market cap is R$488.77B.
      When is CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A’s upcoming earnings report date?
      CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A’s upcoming earnings report date is Oct 28, 2026 which is in 86 days.
        How were CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A’s earnings last quarter?
        CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A released its earnings results on Jul 22, 2026. The company reported $0.001 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
          Is CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A overvalued?
          According to Wall Street analysts CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A pay dividends?
            CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A does not currently pay dividends.
            What is CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A’s EPS estimate?
            CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A have?
            CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A has 7,191,522,500 shares outstanding.
              What happened to CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A’s price movement after its last earnings report?
              CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A reported an EPS of $0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.672%.
                Which hedge fund is a major shareholder of CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A?
                Currently, no hedge funds are holding shares in BR:CHME34
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  CME Group Inc Shs A Unsponsored Brazilian Depository Receipt Repr 1/4 Sh A (CHME34) Earnings & Revenues

                  Historic Earnings Reports
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  B1CS34
                  Barclays PLC ADR Unsponsored Brazilian Depositary Receipt Repr 1 ADR
                  ―
                  ―
                  BONY34
                  Bank of New York Mellon Corp Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh
                  ―
                  ―
                  I1CE34
                  Intercontinental Exchange Inc Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh
                  ―
                  ―
                  ITUB3
                  Itau Unibanco Holding S.A.
                  ―
                  ―
                  STCH34
                  Standard Chartered PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.02 Sh
                  ―
                  ―
                  Compare BR:CHME34 Stocks >
                  Popular Stocks